2m 2m 2m 2m 2m 2m 2m
TELOMIR PHARMA (TELO)
NASDAQ
$1.28+$0.02 (+2.00%)
Price as of Jun 23, 2026 6:58 PM EDT- $88.0MMarket Cap
- -28.98%1-Year Change
- BiotechnologyIndustry
TELOMIR PHARMA (TELO)
$1.28+$0.02 (+2.00%)
TELO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.25 | ||
Change | -$0.03 (-2.34%) | ||
Open | $1.28 | ||
High | $1.30 | ||
Low | $1.25 | ||
Previous Close | $1.28 | ||
Volume | 89,359 | ||
30-Day Average Volume | 149,979 | ||
1-Week Change | -2.34% | ||
1-Month Change | -3.10% | ||
1-Year Change | -28.98% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 68.8M | ||
Total Assets | $5.8M | ||
Market Cap | $88.0M | ||
Enterprise Value | $87.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.8M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $5.0M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -43 | ||
PEG | N/A | ||
Price/Free Cash Flow | -50 | ||
Price/Operating Cash Flow | -50 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue